Filing Details
- Accession Number:
- 0001127602-21-010892
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-16 19:45:56
- Reporting Period:
- 2021-03-15
- Accepted Time:
- 2021-03-16 19:45:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1062822 | Lexicon Pharmaceuticals Inc. | LXRX | Pharmaceutical Preparations (2834) | 760474169 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434095 | F James Tessmer | 8800 Technology Forest Place The Woodlands TX 77381 | Vp, Finance & Accounting | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-15 | 10,912 | $6.90 | 71,766 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-03-15 | 12,000 | $3.31 | 83,766 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-15 | 12,000 | $6.93 | 71,766 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-15 | 12,000 | $0.00 | 12,000 | $3.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,980 | 2030-02-06 | No | 4 | M | Direct |
Footnotes
- Executed in multiple trades at prices ranging from $6.90 to $6.92 per share. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Executed in multiple trades at prices ranging from $6.91 to $6.955. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
Billionaire Hedge Funds
